Health

Lilly's Omvoh (mirikizumab-mrkz) Approved by U.S. FDA as a Single-Injection Maintenance Regimen in Adults with Ulcerative Colitis

DailyTrendDailyTrend
Oct 31, 2025 - 08:00
 0  1
INDIANAPOLIS, Oct. 27, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) approved a single-injection, once-monthly maintenance regimen (200 mg/2 mL) of Omvoh (mirikizumab-mrkz)...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Behind the Dismantling of the C.D.C.: Reform or ‘Humiliation’?

Behind the Dismantling of the C.D.C.: Reform or ‘Humili...

DailyTrend Oct 28, 2025  0  1

Study Finds Evidence That Text-Based Therapy Eases Depression

Study Finds Evidence That Text-Based Therapy Eases Depr...

DailyTrend Oct 31, 2025  0  0

Syndax Announces FDA Approval of Revuforj (revumenib) i...

DailyTrend Oct 28, 2025  0  1

FDA Approves Lynkuet (elinzanetant) for Moderate to Sev...

DailyTrend Oct 26, 2025  0  0

Pig Kidney Removed From Transplant Patient After Nine Months

Pig Kidney Removed From Transplant Patient After Nine M...

DailyTrend Oct 28, 2025  0  1

A West Texas Children’s Clinic Where Vaccine Suspicion Is Encouraged

A West Texas Children’s Clinic Where Vaccine Suspicion ...

DailyTrend Oct 29, 2025  0  1